Cost-Effectiveness of Eplerenone Compared to Usual Care in Patients With Chronic Heart Failure and NYHA Class II Symptoms, an Australian Perspective

The objective of this study was to determine the cost-effectiveness of eplerenone compared with usual care in patients with chronic heart failure and New York Heart Association (NYHA) Class II symptoms. A Markov model was constructed with 5 health states to reflect NYHA symptom status (Classes I–IV)...

Descripción completa

Detalles Bibliográficos
Autores principales: Ademi, Zanfina, Pasupathi, Kumar, Liew, Danny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863773/
https://www.ncbi.nlm.nih.gov/pubmed/27149456
http://dx.doi.org/10.1097/MD.0000000000003531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863773/
https://www.ncbi.nlm.nih.gov/pubmed/27149456
http://dx.doi.org/10.1097/MD.0000000000003531

Ejemplares similares